Detail Information

Publications2

..To demonstrate a lack of effect of steady-state concentrations of cilomilast, a new oral phosphodiesterase 4 inhibitor for the treatment of chronic obstructive pulmonary disease, on warfarin-induced anticoagulation...

Cilomilast (Ariflo) does not potentiate the cardiovascular effects of inhaled salbutamol